You should talk with your healthcare provider prior to taking this medication if you:
- Have low blood calcium (hypocalcemia)
- Cannot sit or stand for one hour
- Have kidney disease, including kidney failure (renal failure)
- Have difficulty swallowing or other problems with your esophagus
- Have any allergies, including allergies to food, dyes, or preservatives.
Also, let your healthcare provider know if you are:
- Pregnant or thinking of becoming pregnant
- Planning to have a dental procedure.
Make sure to tell your healthcare provider about all medicines you are taking, including prescription and non-prescription medicines, vitamins, and herbal supplements.
(Click Precautions and Warnings With Ibandronate to learn more, including information on who should not take the drug.)
Ibandronate belongs to a group of medications known as bisphosphonates. The drug binds to certain cells in bones and slows the rate at which they break down.
Ibandronate has been evaluated in a large study involving almost 3,000 postmenopausal women with osteoporosis. In this study, ibandronate reduced the risk of vertebral fractures (broken spinal bones) by about half. The drug did not seem to reduce the risk of other types of broken bones. It also increased bone mineral density (a measure of the strength of bones) in the spine and hip.
Ibandronate can also be used to prevent osteoporosis in postmenopausal women with risk factors for the disease. In studies of ibandronate for osteoporosis prevention, women taking the medication showed increased bone mineral density, while those not taking it actually experienced bone loss.